Comprehensive genomic profiling in SMARCA4-deficient NSCLC commonly identifies mutations in critical oncogenes such as TP53 (80%), LRP1B (40%), STK11 (27%), KEAP1 (27%), and KRAS (20%). Here, SMARCA4 is linked to non-small cell lung carcinoma.